These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18442323)

  • 21. A century-old debate on protein aggregation and neurodegeneration enters the clinic.
    Lansbury PT; Lashuel HA
    Nature; 2006 Oct; 443(7113):774-9. PubMed ID: 17051203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causative Links between Protein Aggregation and Oxidative Stress: A Review.
    Lévy E; El Banna N; Baïlle D; Heneman-Masurel A; Truchet S; Rezaei H; Huang ME; Béringue V; Martin D; Vernis L
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31405050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
    Gaggelli E; Kozlowski H; Valensin D; Valensin G
    Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
    [No Abstract]   [Full Text] [Related]  

  • 24. Are synucleinopathies prion-like disorders?
    Angot E; Steiner JA; Hansen C; Li JY; Brundin P
    Lancet Neurol; 2010 Nov; 9(11):1128-38. PubMed ID: 20846907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
    Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
    J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delineating common molecular mechanisms in Alzheimer's and prion diseases.
    Barnham KJ; Cappai R; Beyreuther K; Masters CL; Hill AF
    Trends Biochem Sci; 2006 Aug; 31(8):465-72. PubMed ID: 16820299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of misfolded Aβ oligomers for sensitive biochemical diagnosis of Alzheimer's disease.
    Salvadores N; Shahnawaz M; Scarpini E; Tagliavini F; Soto C
    Cell Rep; 2014 Apr; 7(1):261-8. PubMed ID: 24656814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards further reduction and replacement of animal bioassays in prion research by cell and protein misfolding cyclic amplification assays.
    Boerner S; Wagenführ K; Daus ML; Thomzig A; Beekes M
    Lab Anim; 2013 Apr; 47(2):106-15. PubMed ID: 23479773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
    Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
    Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Same causes, same cures.
    Zhang HY
    Biochem Biophys Res Commun; 2006 Dec; 351(3):578-81. PubMed ID: 17081501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neurodegenerative amyloidoses: the yeast model].
    Vishnevskaia AB; Kushnirov VV; Ter-Avanesian MD
    Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using budding yeast to screen for anti-prion drugs.
    Tribouillard D; Bach S; Gug F; Desban N; Beringue V; Andrieu T; Dormont D; Galons H; Laude H; Vilette D; Blondel M
    Biotechnol J; 2006 Jan; 1(1):58-67. PubMed ID: 16892225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterizing Prion-Like Protein Aggregation: Emerging Nanopore-Based Approaches.
    Meyer N; Torrent J; Balme S
    Small Methods; 2024 Apr; ():e2400058. PubMed ID: 38644684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular processes underpinning prion-like spreading and seed amplification in protein aggregation.
    Meisl G; Knowles TP; Klenerman D
    Curr Opin Neurobiol; 2020 Apr; 61():58-64. PubMed ID: 32092527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of scrapie prion precipitation with phosphotungstate anions.
    Levine DJ; Stöhr J; Falese LE; Ollesch J; Wille H; Prusiner SB; Long JR
    ACS Chem Biol; 2015 May; 10(5):1269-77. PubMed ID: 25695325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prion disease blood test using immunoprecipitation and improved quaking-induced conversion.
    Orrú CD; Wilham JM; Raymond LD; Kuhn F; Schroeder B; Raeber AJ; Caughey B
    mBio; 2011; 2(3):e00078-11. PubMed ID: 21558432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A highly sensitive diagnostic assay for aggregate-related diseases, including prion diseases and Alzheimer's disease.
    Birkmann E; Henke F; Funke SA; Bannach O; Riesner D; Willbold D
    Rejuvenation Res; 2008 Apr; 11(2):359-63. PubMed ID: 18442323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An ultrasensitive assay for diagnosis of Alzheimer's disease.
    Funke SA; Birkmann E; Henke F; Görtz P; Lange-Asschenfeldt C; Riesner D; Willbold D
    Rejuvenation Res; 2008 Apr; 11(2):315-8. PubMed ID: 18328004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interesting not only as differential Alzheimer dementia diagnosis. Bovine spongiform encephalopathy and other prion diseases].
    Kretzschmar H
    MMW Fortschr Med; 2000 Sep; 142(39):34-8. PubMed ID: 11072695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Counting of single prion particles bound to a capture-antibody surface (surface-FIDA).
    Birkmann E; Henke F; Weinmann N; Dumpitak C; Groschup M; Funke A; Willbold D; Riesner D
    Vet Microbiol; 2007 Aug; 123(4):294-304. PubMed ID: 17499942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.